Integrative Research Institute
Sacramento, California, 95819, United States
Location status: Recruiting
Location contact
Nasima Afzal
CONTACT
Raja Sivamani, MD
PRINCIPAL_INVESTIGATOR
Rubaina Dang, ND
SUB_INVESTIGATOR
Sarah Adnan
CONTACT
NCT Number: NCT06571721
Investigate the topical use of almond oil, almond oil augmented with 0.5% vitamin E, 0.025% tretinoin oil augmented with castor oil on the appearance of facial fine lines and wrinkles, pigmentation, hydration, trans-epidermal water loss, and sebum excretion rate.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Sacramento, California, 95819, United States
Location status: Recruiting
Nasima Afzal
CONTACT
Raja Sivamani, MD
PRINCIPAL_INVESTIGATOR
Rubaina Dang, ND
SUB_INVESTIGATOR
Sarah Adnan
CONTACT
The natural cosmetic market is a multi-billion dollar industry. Nutraceuticals and food-based cosmetics are a growing trend within dermatology. Almonds are a rich dietary source of a range of fatty acids, phytochemical polyphenols, and antioxidants. Our previous study was a double blinded study that compared almond consumption interventions to a calorie matched intervention over 16 weeks. The study determined that that there was a statistically significant 8.41% improvement in wrinkle severity in the women that received almond supplementation. This proposal aims to now understand how the topical application of almond oil may influence the appearance of wrinkles and facial tone in post-menopausal women. Almond oil is rich in fatty acids and alpha-tocopherol. Tocopherol inhibits melanogenesis in melanocytes and topical alpha tocopherol has been shown to improve skin antioxidants and hyperpigmentation. A challenge of almond oil is that it is prone to oxidation due to its high unsaturated fatty acid concentrations. However, tocopherol has also been shown to improve almond oil stability.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1-2 Drops of randomized topical product will be applied on entire face nightly.
1-2 Drops of randomized topical product will be applied on entire face nightly.
1-2 Drops of randomized topical product will be applied on entire face nightly.
Time frame: 16 Weeks
Change in severity of wrinkles measured by photographic analysis (BTBP 3D Camera System)
Time frame: 16 Weeks
Change in the appearance of facial pigmentation by high resolution photography (BTBP Clarity Pro) and measures intensity of facial pigmentation. Higher scores indicate darker pigmentation.
Time frame: 16 Weeks
Change in the appearance of facial pigmentation will be measured on both cheeks through the use of a handheld device known as the SkinColorCatch with quantitative output for pigment intensity.
Time frame: 16 Weeks
Change in skin hydration will be measured on both cheeks through the use of a non-invasive device known as the Moisturemeter.
Time frame: 16 Weeks
Measure of skin sebum via sebumeter
Time frame: 16 Weeks
A 6 question survey based on the self-assessment about the tolerability of the topical skin product. The scale ranges from 0-3 with 0 being the best outcome possible and with 3 being the worst. "0" as none, "1" as mild, "2" as moderate, or "3" as severe.
Time frame: 16 Weeks
Change in transepidermal water loss (TEWL) using the Vapometer
Contact information is provided by the study sponsor or research team.
Integrative Skin Science and Research
Industry
Prospective, Double-Blinded, Randomized Study of Topical Almond Oil and Tretinoin on Facial Wrinkles
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04742803
Cardiovascular Diseases, Collagen Degeneration
New York, United States
View Trial DetailsNCT06243744
Collagen Degeneration, Collagen Shrinkage
Bradenton, Florida, United States
View Trial DetailsNCT04621383
Atrophy, Collagen Degeneration
Londrina, Paraná, Brazil
View Trial DetailsNCT06645366
Cicatrix, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Greenwood Village, Colorado, United States
View Trial Details